Diagnosis, prevention, medicine

Information for Consumers

2017-09-05

The private joint stock company «SCIENTIFIC-PRODUCTION COMPANY «DIAPROPH-MED» informs about the introduction on market of new medical device for in vitro diagnostics - Controls for Rapid Plasma Reagin (RPR) Test.

The conformity assessment procedure was carried out in accordance with Appendix 3 to the Technical Regulations on Medical Devices for In Vitro Diagnostics, approved by Resolution of the Cabinet of Ministers of October 2, 2013, No. 754.